Article Information
History
- December 16, 2020.
Article Versions
- Version 1 (September 14, 2020 - 03:48).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Alexander S. Hatoum1,*,
- Frank R. Wendt2,
- Marco Galimberti2,
- Renato Polimanti2,3,
- Benjamin Neale4,5,
- Henry R. Kranzler6,7,
- Joel Gelernter*,2,3,8,9,
- Howard J. Edenberg*,10,11 and
- Arpana Agrawal*,1
- 1Washington University in St. Louis, School of Medicine, Department of Psychiatry, USA
- 2Department of Psychiatry, Division of Human Genetics, Yale School of Medicine, New Haven, CT, USA
- 3Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA
- 4Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- 5Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA
- 6Center for Studies of Addiction, Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
- 7VISN 4 MIRECC, Crescenz VAMC, Philadelphia, PA, USA
- 8Department of Genetics, Yale School of Medicine, New Haven, CT, USA
- 9Department of Neuroscience, Yale School of Medicine, New Haven, CT, USA
- 10Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA
- 11Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA
- ↵* Corresponding author; email: ashatoum{at}wustl.edu
↵* These authors contributed equally to the work
Posted December 16, 2020.
Genetic Data Can Lead to Medical Discrimination: Opioid Use Disorder as a Cautionary Tale
